Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Apr;40(1):381–388. doi: 10.1128/iai.40.1.381-388.1983

Monoclonal antibodies against three major glycoproteins of varicella-zoster virus.

C Grose, D P Edwards, W E Friedrichs, K A Weigle, W L McGuire
PMCID: PMC264858  PMID: 6299963

Abstract

Varicella-zoster virus (VZV) codes for three prominent glycoproteins--gp62, gp98, and gp118--in infected cell cultures. To characterize individually these known immunogens, we first inoculated BALB/c mice with crude VZV extracts, produced hybridoma cultures by Köhler-Milstein cell-fusion technology, and screened culture supernatants by indirect immunofluorescence for reactivity directed against unfixed VZV-infected cells (FAMA assay). Supernatants from five independently derived and subcloned hybridomas with a high VZV-FAMA titer but no reactivity against either uninfected or herpes simplex virus-infected cells were further analyzed by immunoprecipitation of [3H]fucose-labeled and detergent-solubilized VZV antigen preparations. Fractionation of the precipitates by sodium dodecyl sulfate-polyacrylamide gel electrophoresis demonstrated that four monoclonal antibodies reacted with both gp62 and gp98, and one precipitated only gp118. The profiles were unchanged whether performed under reducing or nonreducing conditions. When assayed for neutralizing activity, the secretory product of the single anti-gp118 hybridoma, but not the supernatants from the four anti-gp62/gp98 clones, inhibited VZV plaque formation by greater than 80%. Thus, at least one of the glycosylated antigens detected by the FAMA assay is a determinant which elicits neutralizing activity.

Full text

PDF
384

Images in this article

383Image
on p.383
384Image
on p.384
385Image
on p.385
385Image
on p.385
386Image
on p.386

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balachandran N., Harnish D., Killington R. A., Bacchetti S., Rawls W. E. Monoclonal antibodies to two glycoproteins of herpes simplex virus type 2. J Virol. 1981 Aug;39(2):438–446. doi: 10.1128/jvi.39.2.438-446.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bonner W. M., Laskey R. A. A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem. 1974 Jul 1;46(1):83–88. doi: 10.1111/j.1432-1033.1974.tb03599.x. [DOI] [PubMed] [Google Scholar]
  3. Dimitriadis G. J. Effect of detergents on antibody-antigen interaction. Anal Biochem. 1979 Oct 1;98(2):445–451. doi: 10.1016/0003-2697(79)90165-9. [DOI] [PubMed] [Google Scholar]
  4. Eberle R., Courtney R. J. Multimeric forms of herpes simplex virus type 2 glycoproteins. J Virol. 1982 Jan;41(1):348–351. doi: 10.1128/jvi.41.1.348-351.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eisenberg R. J., Ponce de Leon M., Pereira L., Long D., Cohen G. H. Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody. J Virol. 1982 Mar;41(3):1099–1104. doi: 10.1128/jvi.41.3.1099-1104.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gershon A. A., Steinberg S., Brunell P. A. Zoster immune globulin. A further assessment. N Engl J Med. 1974 Jan 31;290(5):243–245. doi: 10.1056/NEJM197401312900503. [DOI] [PubMed] [Google Scholar]
  7. Gilman S. C., Docherty J. J., Rawls W. E. Antibody responses in humans to individual proteins of herpes simplex viruses. Infect Immun. 1981 Dec;34(3):880–887. doi: 10.1128/iai.34.3.880-887.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goding J. W. Use of staphylococcal protein A as an immunological reagent. J Immunol Methods. 1978;20:241–253. doi: 10.1016/0022-1759(78)90259-4. [DOI] [PubMed] [Google Scholar]
  9. Grose C., Brunel P. A. Varicella-zoster virus: isolation and propagation in human melanoma cells at 36 and 32 degrees C. Infect Immun. 1978 Jan;19(1):199–203. doi: 10.1128/iai.19.1.199-203.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Grose C., Edmond B. J., Brunell P. A. Complement-enhanced neutralizing antibody response to varicella-zoster virus. J Infect Dis. 1979 Apr;139(4):432–437. doi: 10.1093/infdis/139.4.432. [DOI] [PubMed] [Google Scholar]
  11. Grose C., Edmond B. J., Friedrichs W. E. Immunogenic glycoproteins of laboratory and vaccine strains of Varicella-Zoster virus. Infect Immun. 1981 Mar;31(3):1044–1053. doi: 10.1128/iai.31.3.1044-1053.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grose C., Friedrichs W. E. Immunoprecipitable polypeptides specified by varicella-zoster virus. Virology. 1982 Apr 15;118(1):86–95. doi: 10.1016/0042-6822(82)90322-1. [DOI] [PubMed] [Google Scholar]
  13. Grose C. Immunization of inbred guinea pigs with varicella-zoster virus grown in a syngeneic transformed embryo cell line. J Clin Microbiol. 1981 Aug;14(2):229–231. doi: 10.1128/jcm.14.2.229-231.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Grose C. The synthesis of glycoproteins in human melanoma cells infected with varicella-zoster virus. Virology. 1980 Feb;101(1):1–9. doi: 10.1016/0042-6822(80)90478-x. [DOI] [PubMed] [Google Scholar]
  15. Grose C. Zoster in children with cancer: radioimmune precipitation profiles of sera before and after illness. J Infect Dis. 1983 Jan;147(1):47–56. doi: 10.1093/infdis/147.1.47. [DOI] [PubMed] [Google Scholar]
  16. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  17. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  18. Norrild B. Immunochemistry of herpes simplex virus glycoproteins. Curr Top Microbiol Immunol. 1980;90:67–106. doi: 10.1007/978-3-642-67717-5_4. [DOI] [PubMed] [Google Scholar]
  19. Pereira L., Dondero D., Norrild B., Roizman B. Differential immunologic reactivity and processing of glycoproteins gA and gB of herpes simplex virus types 1 and 2 made in Vero and HEp-2 cells. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5202–5206. doi: 10.1073/pnas.78.8.5202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pereira L., Hoffman M., Gallo D., Cremer N. Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants. Infect Immun. 1982 Jun;36(3):924–932. doi: 10.1128/iai.36.3.924-932.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pereira L., Klassen T., Baringer J. R. Type-common and type-specific monoclonal antibody to herpes simplex virus type 1. Infect Immun. 1980 Aug;29(2):724–732. doi: 10.1128/iai.29.2.724-732.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Powell K. L., Buchan A., Sim C., Watson D. H. Type-specific protein in herpes simplex virus envelope reacts with neutralising antibody. Nature. 1974 May 24;249(455):360–361. doi: 10.1038/249360a0. [DOI] [PubMed] [Google Scholar]
  23. Shemer Y., Leventon-Kriss S., Sarov I. Isolation and polypeptide characterization of varicella-zoster virus. Virology. 1980 Oct 15;106(1):133–140. doi: 10.1016/0042-6822(80)90228-7. [DOI] [PubMed] [Google Scholar]
  24. Showalter S. D., Zweig M., Hampar B. Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4. Infect Immun. 1981 Dec;34(3):684–692. doi: 10.1128/iai.34.3.684-692.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Strnad B. C., Schuster T., Klein R., Hopkins R. F., 3rd, Witmer T., Neubauer R. H., Rabin H. Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen. J Virol. 1982 Jan;41(1):258–264. doi: 10.1128/jvi.41.1.258-264.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Waehneldt T. V. Sodium dodecyl sulfate in protein chemistry. Biosystems. 1975 Mar;6(3):176–187. doi: 10.1016/0303-2647(75)90025-8. [DOI] [PubMed] [Google Scholar]
  27. Watson D. H., Wildy P. The preparation of 'monoprecipitin' antisera to herpes virus specific antigens. J Gen Virol. 1969 Mar;4(2):163–168. doi: 10.1099/0022-1317-4-2-163. [DOI] [PubMed] [Google Scholar]
  28. Williams V., Gershon A., Brunell P. A. Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence. J Infect Dis. 1974 Dec;130(6):669–672. doi: 10.1093/infdis/130.6.669. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES